Aspergilloma for md exams 10 marks answer

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have comprehensive material to write a thorough 10-mark answer. Let me compile everything:

Aspergilloma

Definition

Aspergilloma (also called mycetoma or fungus ball) is the saprophytic colonization of a pre-existing pulmonary cavity by Aspergillus species, most commonly A. fumigatus. The fungal hyphae, mucus, cellular debris, and fibrin accumulate within the cavity to form a rounded mass. It is now classified as a form of Chronic Pulmonary Aspergillosis (CPA).

Fishman's Pulmonary Diseases and Disorders, p. 2329

Etiology and Predisposing Factors

Aspergillomas are broadly divided into:

Secondary aspergilloma (common) - colonization of a pre-existing cavity:

Tuberculosis is the most common predisposing condition globally. Aspergilloma occurs in 11-17% of post-TB cavities; 20% of patients recovering from cavitary TB develop it within 3 years. In developing countries, TB accounts for >90% of cases.
Sarcoidosis
Histoplasmosis, blastomycosis
Bronchiectasis, pulmonary fibrosis, asbestosis
Lung abscess, pneumonia
Pulmonary cysts
Ankylosing spondylitis
AIDS (especially atypical Pneumocystis jirovecii pneumonia)
Pulmonary infarction, adenocarcinoma, rheumatoid nodules

Primary aspergilloma (rare) - Aspergillus itself initiates cavity formation via:

Invasive Pulmonary Aspergillosis (IPA) with neutrophil recovery
Chronic Necrotizing Pulmonary Aspergillosis (CNPA)
ABPA causing bronchiectasis with distal fungal growth (aspergillomas found in ~7% of ABPA patients)

Note: A. niger is particularly implicated in diabetic patients; it produces oxalic acid crystals visible in sputum.

Fishman's, p. 2329

Pathophysiology

The fungus proliferates within the cavity as a biofilm. Typical biofilm structures have been demonstrated in aspergillomas both in human specimens and in murine IPA models. The biofilm architecture critically limits penetration by antifungal agents, making medical treatment difficult.

The fungal mass is held within the cavity by gravity and moves with positional change - this forms the basis of the classical radiological sign. The cavity wall develops hypertrophic bronchial arteries, which are the source of hemoptysis.

Spontaneous resolution occurs in 7-10% of cases, often associated with bacterial superinfection of the cavity. Aspergillomas only rarely increase in size.

Fishman's, p. 2329

Clinical Features

Feature	Detail
Hemoptysis	Most characteristic; present in 50-90% of patients. Usually mild and recurrent but can be massive and life-threatening
Cough	Common, productive
Dyspnea	Reflects underlying lung disease
Weight loss, fatigue	Constitutional features
Chest pain	Pleuritic if pleural involvement
Fever	Usually absent unless secondary infection
Asymptomatic	A significant proportion discovered incidentally

Hemoptysis is the dominant clinical concern. It results from mechanical friction of the fungal ball against the cavity wall eroding hypertrophic bronchial arteries, release of mycotoxins and proteolytic enzymes, and endotoxin-mediated vascular injury.

Diagnosis

1. Radiology

Chest X-ray: A solid, rounded mass (3-5 cm diameter) within a cavity, partially surrounded by a crescent of air - the Monod's sign (air-crescent sign). Marked pleural thickening is often present.

Chest X-ray: Monod's sign/air crescent sign in aspergilloma - fungus ball within upper lobe cavities (arrows)

Chest radiograph showing bilateral apical aspergillomas with the air-crescent (Monod's) sign (arrows). Goldman-Cecil Medicine.

Radiographic appearances: A) Classic Monod's sign with pleural thickening in post-TB aspergilloma. B) Thin-walled cavity aspergilloma in ankylosing spondylitis. C) Decubitus film showing mobility of the fungus ball.

Fig. A: Post-TB aspergilloma with classic Monod's sign and pleural thickening. B: Thin-walled cavity aspergilloma in ankylosing spondylitis. C: Decubitus film demonstrating mobility of the fungus ball (positional change). - Fishman's Pulmonary Diseases

Key radiological points:

Upper lung field predominance (reflecting TB cavity distribution)
Lesion moves in decubitus position (mobile fungus ball)
CT scan confirms features not apparent on X-ray; globules of gas visible within the hyphal mass; CT angiography identifies hypertrophic bronchial arteries supplying the cystic wall - important for planning bronchial artery embolization (BAE)

2. Microbiology

Sputum culture positive for Aspergillus in >50% of patients but lacks sensitivity and specificity
BAL culture may be used in atypical cases

3. Serology (most important diagnostic test)

Precipitating antibodies (precipitins/IgG) to Aspergillus antigens: present in >95% of patients with aspergilloma - the most reliable diagnostic marker
Patients on corticosteroids may be seronegative
Eosinophilia and elevated IgE suggest allergy but are inconsistent

4. Histopathology / Biopsy

May be needed in atypical cases
Shows septate hyphae with characteristic 45-degree angle branching

Poor Prognostic Indicators

Progressive increase in size or number of aspergillomas
Severe underlying lung disease with poor lung reserve
Immunosuppressive therapy or AIDS
Sarcoidosis as the predisposing condition
Rising Aspergillus-specific IgG titer
Repeated episodes of severe hemoptysis

Treatment

There is no consensus on treatment due to lack of controlled studies. Management must be individualized based on the severity of symptoms, underlying lung reserve, and operative fitness.

1. Conservative Management

Asymptomatic patients: careful observation with periodic chest X-rays, without specific medical or surgical intervention.

2. Control of Hemoptysis

Bronchial Artery Embolization (BAE):

First-line emergency measure for acute massive hemoptysis
Temporary control in most cases; recurrence is common
CT angiography helps identify the culprit bronchial arteries

Intracavitary instillation of antifungal agents:

CT-guided percutaneous instillation of Amphotericin B (AMB-D) - effective for massive hemoptysis in poor surgical candidates
Resolution of hemoptysis has been documented in several cases

Radiation therapy:

Shown to be effective even in massive hemoptysis
Recommended for recurrence of life-threatening hemoptysis after BAE

3. Medical (Antifungal) Therapy

Itraconazole (oral, 200-400 mg/day): The most studied antifungal for aspergilloma. Non-controlled studies show variable efficacy; capsule formulation used in several series. Limited penetration due to biofilm is the main drawback.
Voriconazole: Used for CPA; data for simple aspergilloma less robust
Overall, systemic antifungals are used, particularly in non-surgical candidates, but response rates are modest

4. Surgical Treatment

Surgical resection is the definitive treatment but carries significant morbidity:

Indications: Life-threatening hemoptysis, progressive increase in size, failure of conservative management
Procedure: Lobectomy is the standard; pneumonectomy rarely required
Complications: Bronchopleural fistula, pleural Aspergillus infection, prolonged air leak - limiting its use
Cavernostomy (under local anesthesia) is an alternative for unfit patients; should be a last resort due to associated mortality and mediocre results

Approach	Indication
Observation	Asymptomatic, small, stable
BAE	Acute massive hemoptysis
Intracavitary AMB	Poor surgical candidate, hemoptysis
Itraconazole	Non-surgical management
Surgery (lobectomy)	Life-threatening hemoptysis, progressive disease
Cavernostomy	Last resort in surgical high-risk

Complications

Massive / fatal hemoptysis - the main cause of death
Pleural aspergillosis - may complicate surgical resection or develop via bronchopleural fistula
Pneumothorax - rare, reported in hematologic malignancies
Secondary bacterial infection of the cavity
ABPA perpetuation - aspergilloma may sustain the allergic cycle in ABPA

Key Exam Points (Summary Table)

Feature	Key Fact
Causative organism	Aspergillus fumigatus (most common); A. niger in diabetics
Commonest predisposing cause	Post-tubercular cavity
Pathology	Fungus ball in pre-existing cavity; biofilm structure
Classic symptom	Hemoptysis (50-90%)
Classic X-ray sign	Monod's sign / air crescent sign
Best serological test	Precipitins (IgG) to Aspergillus - positive in >95%
Spontaneous resolution	7-10% of cases
Treatment of massive hemoptysis	Bronchial artery embolization (BAE)
Definitive treatment	Surgical resection (lobectomy)
Oral antifungal of choice	Itraconazole
Classification	Form of Chronic Pulmonary Aspergillosis (CPA)

Sources: Fishman's Pulmonary Diseases and Disorders (pp. 2329-2330); Goldman-Cecil Medicine; Harrison's Principles of Internal Medicine 22E; Murray & Nadel's Textbook of Respiratory Medicine.

This is a shared conversation. Sign in to Orris to start your own chat.